Biocept Inc (Biocept Inc (BIOC) has risen Tuesday morning, with the stock gaining 15.34% in pre-market trading to 5.94.
BIOC's short-term technical score of 6 indicates that the stock has traded less bullishly over the last month than 94% of stocks on the market. In the Diagnostics & Research industry, which ranks 124 out of 146 industries, the stock ranks higher than 5% of stocks.
Biocept Inc has fallen 14.59% over the past month, closing at $6.16 on March 2. During this period of time, the stock fell as low as $5.10 and as high as $6.99. BIOC has an average analyst recommendation of Strong Buy. The company has an average price target of $20.00.
Biocept Inc has a Long-Term Technical rank of 30. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 70% of the market scoring higher. In the Diagnostics & Research industry which is number 120 by this metric, BIOC ranks better than 41% of stocks.
Important Dates for Investors in BIOC:
-Biocept Inc is set to release earnings on 6/27/2021. During their last earnings release the company posted EPS of $-3.27. -We do not have a set dividend date for Biocept Inc at this time. Click Here to get the full Stock Score Report on Biocept Inc (BIOC) Stock.
